Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Bruxelles, Belgium Clinical Trials

A listing of Bruxelles, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (12) clinical trials

Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units

Patients who are hospitalized in intensive care unit (ICU) require basic nursing care to improve patient hygiene, to promote comfort, to prevent pressure ulcer, and foot or hand's retractations. Those nursing cares require mobilization very frequently which expose critically ill patients to occurrence of serious adverse events (SAE) such as ...

Phase N/A

0.0 miles

Learn More »

A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

The objective of this study is to evaluate the effect of LJPC-501 infusion on mean arterial pressure (MAP) as assessed by standard of care vasopressor dose reduction in pediatric patients with catecholamine-resistant hypotension (CRH). In addition, this study will evaluate the safety and tolerability of LJPC-501 in pediatric patients, evaluate ...

Phase

0.0 miles

Learn More »

Belgian Central Sleep Apnea REgistry

Central sleep apnea (CSA) is characterized by intermittent cessation or decrease of airflow and effort of breathing during sleep. The diagnostic criteria for CSA varies according to the type of CSA (e.g. CSA due to cardiac failure, due to a medication, ...). CSA is defined as: (1) an apnea/hypopnea index ...

Phase N/A

0.0 miles

Learn More »

The FIERCE-22 study is a Phase 1b/2 study to evaluate the effectiveness and safety of vofatamab (B-701) in combination with the immunotherapy drug pembrolizumab in the treatment of subjects with Stage IV, locally advanced or metastatic FGFR3 wild-type (WT) or mutation positive UCC who have previously been treated with a ...

Phase

0.0 miles

Learn More »

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.

Phase

1.9 miles

Learn More »

Ankle/Brachial Non-Invasive Blood Pressure Difference During General Anesthesia

Brachial non-invasive blood pressure (NIBP) monitoring is recommended as part of the American Society of Anesthesiology (ASA) basic monitoring package. Although brachial NIBP is often practical, some surgeries and patients may require NIBP measurement elsewhere (e.g. the ankle). Several studies have shown that ankle NIBP overestimates brachial NIBP measurements. Algorithms ...

Phase N/A

2.36 miles

Learn More »

Prediction of the Recovery of Neuromuscular Transmission After Curarization

The vast majority of patients receive neuromuscular blockers during surgical procedures, either as a single injection to facilitate intubation or as repeated injections to induce muscle relaxation necessary for surgery. The action of neuromuscular blockers is monitored by measuring the contraction force of the adductor of the thumb after stimulation ...

Phase N/A

2.36 miles

Learn More »

Screening for Emotional Behavioral and Developmental Disorders in Children With Functional Constipation.

Constipation and fecal incontinence are common problems in childhood. In the absence of an underlying disease they are classified as functional constipation (FC) and functional non-retentive fecal incontinence (FNRFI). Functional constipation is often associated with functional impaction that may lead to fecal incontinence. Most of these children respond well to ...

Phase N/A

2.46 miles

Learn More »

Development and Validation of an Android-based Application for Anaesthesia Neuromuscular Monitoring

Since Harold Randall Griffith pioneered by the use of curare during anaesthesia by administering it to a young man during an appendectomy in Montreal, the practice of anaesthesiology has completely changed and the world of Neuromuscular Blocking has been thoroughly fine-tuned: increased knowledge and clinical experience, development of new Neuromuscular ...

Phase N/A

2.46 miles

Learn More »

Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive Locally Advanced or Metastatic Solid Tumors

The primary objective of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of rogaratinib in combination with copanlisib in patients with locally advanced or metastatic solid tumors that are mRNA-positive for at least one FGFR1-4 subtype. The secondary objectives ...

Phase

3.32 miles

Learn More »